#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Trigeminal neuralgia Haematological malignancy Salivary gland cancer Chronic lymphocytic leukaemia recurrent Plasma cell myeloma Dementia Haemolytic uraemic syndrome Wiskott-Aldrich syndrome Acute promyelocytic leukaemia Glycogen storage disease type V Small intestine neuroendocrine tumour Hyperphagia Pancreatic carcinoma Sickle cell anaemia Hypomagnesaemia More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Diagnostics Combined immunodeficiency – Treatment Chondrosarcoma – Basic Information VEXAS syndrome – Life with Disease Hereditary hypophosphataemic rickets – Treatment Congenital nephrogenic diabetes insipidus – Diagnostics Primary biliary cholangitis Bronchiolitis obliterans syndrome – Basic Information Combined immunodeficiency – Trials in Disease Chondrosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-ALANINE Rusfertide NERANDOMILAST Psilocybine Voclosporin ALE.P02 Infliximab Fluoroethyltyrosine F-18 Mitapivat Cobamamide OSIMERTINIB MESYLATE REGN7544 Delandistrogene Moxeparvovec Mometasone Furoate Ph. Eur. Monalizumab Air, Medicinal Sunvozertinib Vorasidenib Crizanlizumab MAGNESIUM CARBONATE HEAVY More therapies…

    Learn about Your Condition

    Breast cancer in situ Infertility female Radiation skin injury Hairy cell leukaemia recurrent Nodal osteoarthritis Hepatic cirrhosis Migraine Adenomyosis Neurodermatitis Synovial sarcoma metastatic Haemorrhage Renal disorder Autoimmune disorder Ankylosing spondylitis Rhinitis allergic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Baricitinib
    France Germany Hungary Poland Spain

  • Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Finland France Germany Greece +9

  • Study on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Vibozilimod
    Estonia Poland

  • Study on the Effects of Botulinum Toxin Type A for Treating Moderate to Severe Forehead Lines in Adults

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A
    Austria Germany

  • Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Nemolizumab
    Hungary Poland Spain
Previous Page
1 … 61 62 63 64 65 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!